WHO ICTRP trial
Targeted radiotherapy for AL-Amyloidosis – TRALA
ISRCTN13400668 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN13400668 |
|---|---|
| Public title | Targeted radiotherapy for AL-Amyloidosis – TRALA |
| Scientific title | A Phase I/IIa Study of Targeted Radiotherapy alone for Stem Cell Transplant Conditioning in Systemic AL Amyloidosis |
| Primary sponsor | University Hospital Southampton NHS Foundation Trust |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase I/II |
| Countries | United Kingdom;England |
| Conditions | Systemic AL-Amyloidosis Nutritional, Metabolic, Endocrine Amyloidosis |
| Interventions | Three treatment levels with step-wise increase of the infused [90Y]-labelled anti-CD66 radiation activity. There will be 3 patients in each cohort (which can be expanded if required due to toxicities seen). A minimum of 12 patients maximum… |
| Registration date | Nov 15, 2016 |
| Target size | 18 |
| Secondary IDs | 2015-002231-18;19732 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: